Defense Secretary Pete Hegseth has directed the Pentagon to implement mandatory testosterone level screenings for all military personnel over the age of 30 as part of their annual physical examinations. Under the new directive, service members identified with low testosterone levels will be provided the option to receive testosterone replacement therapy, a move aimed at what the Secretary describes as optimizing the biological readiness of the force.
The policy, announced this week, marks a significant shift in military health protocol and follows a series of administrative changes initiated by Hegseth to emphasize a “warrior” ethos within the Department of Defense. According to the Secretary, the initiative is intended to ensure service members possess the “biological foundation required to sustain the fight.”
The High-T Department of War. pic.twitter.com/hlAUq3j2cD— Secretary of War Pete Hegseth (@SecWar) July 15, 2026
Clinical Perspectives on Testosterone Screening
The decision to initiate universal screening has drawn immediate scrutiny from medical organizations. The Endocrine Society stated that there is “insufficient evidence” to support routine testosterone screening for asymptomatic individuals. Medical experts note that testosterone levels naturally fluctuate and decline with age, but they warn that distinguishing between a natural decline and a condition requiring clinical intervention remains a subject of significant professional debate.
Current clinical data suggests that testosterone is already frequently overprescribed in the United States. Research indicates that only 12 percent of men receiving testosterone prescriptions have undergone the appropriate diagnostic testing required to confirm a deficiency. Medical professionals caution that low testosterone can often be a secondary symptom of other chronic health issues, such as obesity or metabolic disorders, which may require different interventions, such as weight management or the use of GLP-1 medications, rather than hormone supplementation.
Military Health Policy and Vaccine Mandates
This initiative is part of a broader shift in the military’s approach to health and wellness. Earlier this year, the Department of Defense moved to end the requirement for annual flu vaccinations for service members. While the Pentagon later reinstated the mandate for new recruits following a significant influenza outbreak at a military boot camp, the initial policy change highlighted a trend toward reevaluating long-standing health requirements.
In a related move this week, Secretary Hegseth launched an internal investigation into the 2021 decision by the Department of Defense to mandate Covid-19 vaccinations for military personnel. These shifts mirror ongoing policy discussions regarding public health mandates within the current administration, including initiatives led by Robert F. Kennedy Jr. at the U.S. Department of Health and Human Services.
The Rising Trend of Testosterone Use
The focus on testosterone within the military coincides with a sharp increase in the civilian use of hormone supplements. According to industry data, the number of testosterone prescriptions in the U.S. grew from 7.3 million in 2019 to more than 11 million in 2024. This trend has sparked a nationwide conversation about the safety and efficacy of hormone replacement therapies.
While historical clinical concerns focused on potential cardiovascular risks associated with supplemental testosterone, more recent research has led some medical proponents to advocate for broader prescribing practices. However, the current scientific consensus does not explicitly support widespread, asymptomatic testing of the type now mandated for the military. As the Department of Defense prepares to roll out these screenings, the long-term impact on service member health, retention, and operational readiness remains to be seen.
Worth a look